Ella Ioffe

Ella Ioffe

Company: Regeneron Pharmaceuticals

Job title: Director


Panel Discussion: Compare Bispecific & Combination Therapeutic Approaches 2:15 pm

Highlighting strengths and weaknesses of the different approaches Discussing the variety of unique drug development challenges that come with these different modalities at the clinical stagesRead more

day: Day Two

Targeting LAG-3 in Cancer Immunotherapy: Advancing Beyond PD-1 Blockade 1:30 pm

Preclinical rationale for therapeutic LAG-3 and PD-1 co-targeting in cancer Fianlimab (anti-LAG-3) & cemiplimab (anti-PD-1) – fully human antibodies for cancer immunotherapy Translational biology to inform clinical development of fianlimab and cemiplimab combinationRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.